The biotech sector is fraught with risk, but that doesn’t mean that every biotech stock should be avoided. To help you identify a few potential winners, we asked a team of healthcare experts to share a biotech stock that they think is a smart buy right now. They picked TG Therapeutics (NASDAQ: TGTX), Alkermes (NASDAQ: ALKS), and Lexicon Pharmaceuticals (NASDAQ: LXRX). Here’s why.